0001140361-15-037103.txt : 20151007 0001140361-15-037103.hdr.sgml : 20151007 20151007180000 ACCESSION NUMBER: 0001140361-15-037103 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151007 FILED AS OF DATE: 20151007 DATE AS OF CHANGE: 20151007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 GATEWAY BLVD. STREET 2: SUITE 125 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 650 GATEWAY BLVD. STREET 2: SUITE 125 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Elaine V CENTRAL INDEX KEY: 0001296907 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 151149745 MAIL ADDRESS: STREET 1: C/O TARGACEPT, INC. STREET 2: 200 EAST FIRST STREET, SUITE 300 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 3 1 doc1.xml FORM 3 X0206 3 2015-10-07 1 0001501989 CytomX Therapeutics, Inc. CTMX 0001296907 Jones Elaine V 235 EAST 42ND STREET NEW YORK NY 10017 1 0 0 0 Exhibit 24.1 - Power of Attorney /s/ Cynthia J. Ladd, attorney-in-fact 2015-10-07 EX-24.1 2 efc15-678_ex241.htm Unassociated Document
POWER OF ATTORNEY
 
Know all by these presents, that the undersigned hereby makes, constitutes and appoints each of Robert C. Goeltz II  and Cynthia J. Ladd, or either of them acting individually, and with full power of substitution, the undersigned's true and lawful attorney-in-fact to:
 
(1)  
prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;
 
(2)  
execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of CytomX Therapeutics, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;
 
(3)  
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and
 
(4)  
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
 
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of September, 2015.

 
 
 /s/ Elaine V. Jones  
    Signature  
       
       
    Elaine V. Jones  
    Print Name